retatrutide ly3437943 triple agonist glp-1 gip glucagon 30 mg — ≥99% HPLC, Scan-to-Verify COA · Merit Sciences Retatrutide and LDL Cholesterol: How

It may be considered for people who have already gone through the standard dosing schedule and may benefit from a higher dose under clinical supervision

When restriction has already been part of the story, adding a medication that suppresses appetite is not a neutral intervention. Gastrointestinal Conditions That Require Caution Because GLP-1 medications slow gastric emptying and affect gut motility, certain GI conditions need special caution

Follow-up appointments allow physicians to encourage self-monitoring and allow tracking of a patients progress by using self-monitored data

Tirzepatide is not approved for patients with type 1 diabetes

There is also a risk of gallbladder problems with Mounjaro